Scroll To Top

drug testing

New Daily HIV Pill Moves Closer to Approval

A Phase 3 clinical study from Merck will look at the use of islatravir for treatment after it was studied for preventative use.

Pharma Bro Found Guilty of Fraud

Martin Shkreli, the bully who hiked up the price of an HIV drug nearly 5,000 percent overnight, now faces up to 20 years in prison.

Trial Drug Aims to Fight HPV Symptoms

A trial drug study will be conducted on Multikine, which has the potential to work with the immune system against tumors and warts created by HPV and HPV/HIV co-infection.